Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-19T04:01:46.937Z Has data issue: false hasContentIssue false

Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: A 10 years retrospective analysis

Published online by Cambridge University Press:  16 April 2020

Y. Gilat*
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel
D.H. Ben-Dor
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel
A. Magen
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel
L. Wolovick
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel
M. Vekslerchik
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel
A. Weizman
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel Sackler Faculty of Medicine, Tel Aviv University, Israel Research Unit, Geha Mental Health Center and Felsenstein Medical Research Center, Petah Tikva, Israel
G. Zalsman
Affiliation:
Child and Adolscent Division, Geha Mental Health Center, 1 Helsinki St, PO Box 102, Petah Tikva 49100, Israel Sackler Faculty of Medicine, Tel Aviv University, Israel Molecular Imaging and Psychopathology Division, Psychaitry Department, Columbia University, NY, USA
*
* Corresponding author. Tel.: +972 3 925 8367; fax: +972 3 924 1041. E-mail address: [email protected]
Get access

Abstract

We examined the trends in prescribing psychotropic drugs to children and adolescents within an inpatients adolescent psychiatric ward in Israel. Data of 414 subjects, ranging from 12- to 22-year-old, covering the years 1997, 2002 and 2007, was examined retrospectively. Analyzed variables included the number and type of drug prescriptions per patient at discharge, the subjects’ age at discharge and the number of diagnoses per patient at discharge. Analysis of variance (ANOVA) with repeated measures was used to evaluate changes between the three calendar years, along the 10-year study period, while Pearson χ2 test was performed for categorical variables. Over the study period the mean age at discharge decreased significantly, by about a year and a half, the mean number of diagnoses increased significantly, from 1.6 to 2.4 diagnoses per patient and the total number of drugs prescribed at discharge increased significantly from 1.48 to 1.93 per patient. Overall, the number of patients who were prescribed mood stabilizers increased by 14%, those who were prescribed antidepressants increased by almost 24%, almost 16% in antipsychotics prescriptions and 51.5% in prescriptions of atypical antipsychotics. Typical antipsychotic prescriptions decreased by 35.5% and accordingly, the number of patients who were prescribed agents for the treatment of extra-pyramidal side effects decreased by almost 24%. Due to a low number of inpatients with attention deficit and hyperactivity disorder (ADHD), no significant statistical conclusion could be drawn regarding trends in psychostimulant prescriptions. Our findings agree with other published studies from the last two decades. The growing use of psychotropic agents in children and adolescents merit a continuous concern with regard to their effects on the developing brain and impact on quality of life and to authorizing these drugs for use in specific young age subgroups.

Type
Original article
Copyright
Copyright © Elsevier Masson SAS 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

1

The two first authors contributed equally to this paper.

References

Behr, ROverzealous prescribing of medications. J Am Acad Child Adolesc Psychiatry 1998; 37: 900901.CrossRefGoogle ScholarPubMed
Carlezon, WA Jr., Konradi, CUnderstanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 2004;47(Suppl. 1):4760.CrossRefGoogle ScholarPubMed
Coyle, JTPsychotropic drug use in very young children. JAMA 2000; 283: 10251030.CrossRefGoogle ScholarPubMed
Hugtenburg, JG, Heerdink, ER, Egberts, ACIncreased psychotropic drug consumption by children in the Netherlands during 1995–2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 2004; 60: 377379.CrossRefGoogle ScholarPubMed
Hunkeler, EM, Fireman, B, Lee, J, Diamond, R, Hamilton, J, He, CX, et al.Trends in Use of Antidepressants, Lithium, and Anticonvulsants in Kaiser Permanente-Insured Youths, 1994–2003. J ChildAdolesc Psychophamacol 2005; 15: 2637.Google ScholarPubMed
Kalverdijk, LJ, Tobi, H, van den Berg, PB, Buiskool, J, Wagenaar, L, Minderaa, RB, et al.Use of antipsychotic drugs among dutch youths between 1997 and 2005. Psychiatr Serv 2008; 59: 554560.CrossRefGoogle ScholarPubMed
Moreno, C, Laje, G, Blanco, C, Jiang, H, Schmidt, AB, Olfson, MNational trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007; 64: 10321039.CrossRefGoogle ScholarPubMed
Najjar, F, Welch, C, Grapentine, WL, Sachs, H, Siniscalchi, J, Price, LHTrends in psychotropic drug use in a child psychiatric hospital from 1991–1998. J Child Adolesc Psychopharmacol 2004; 14: 8793.CrossRefGoogle Scholar
Olfson, M, Marcus, SC, Weissman, MM, Jensen, PSNational trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002; 41: 514521.CrossRefGoogle ScholarPubMed
Patel, NC, Sanchez, RJ, Johnsrud, MT, Crismon, MLTrends in antipsychotic use in a texas medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol 2002; 12: 221229.CrossRefGoogle Scholar
Patel, NC, Crismon, ML, Hoagwood, K, Johnsrud, MT, Rascati, KL, Wilson, JP, et al.Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry 2005; 44: 548556.CrossRefGoogle ScholarPubMed
Safer, DJChanging patterns on psychotropic medications prescribed by child psychiatrists in the 1990s. J Child Adolesc Psychophamacol 1997; 7: 267274.CrossRefGoogle ScholarPubMed
Stubbe, DE, Martin, AThe use of psychotropic medications in young children: the facts, the controversy, and the practice. Conn Med 2000; 64: 329333.Google ScholarPubMed
Vitiello, BPediatric psychopharmacology and the interaction between drugs and the developing brain. Can J Psychiatry 1998; 43: 582584.CrossRefGoogle ScholarPubMed
Vitiello, BAn international perspective on pediatric psychopharmacology. Int Rev Psychiatry 2008; 20: 121126.CrossRefGoogle ScholarPubMed
Walkup, JTIncreasing use of psychotropic medications in children and adolescents: what does it mean? J Child Adolesc Psychopharmacol 2003; 13: 13.CrossRefGoogle ScholarPubMed
Wong, IC, Camilleri-Novak, D, Stephens, PRise in psychotropic drug prescribing in children in the UK: an urgent public health issue. Drug Saf 2003; 26: 11171118.CrossRefGoogle Scholar
Zito, JMCommentary on Dr. Walkup's guest editorial. J Child Adolesc Psychopharmacol 2003; 13: 445447.CrossRefGoogle ScholarPubMed
Zito, JM, Safer, DJ, dosReis, S, Gardner, JF, Boles, M, Lynch, FTrends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283: 10251030.CrossRefGoogle ScholarPubMed
Zito, JM, Safer, DJ, dosReis, S, Gardner, JF, Socken, K, Boles, M, et al.Rising prevalence of antidepressants among US Youths. Pediatrics 2002; 109: 721727.CrossRefGoogle ScholarPubMed
Zito, JM, Safer, DJ, dosReis, S, Gardner, JF, Magder, L, Socken, K, et al.Psychotropic practice patterns for youth. Arch Pediatr Adolesc Med 2003; 157: 1725.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.